Reed Elsevier Ventures is a global venture capital partnership. We are backed by one of the world's largest content, technology and analytics companies, RELX Group.
Our mission is to help build companies that can transform their markets through the application of data, technology and analytics. Since 2000 the two founding partners have invested $200m in Big Data, Digital Health, Internet and Enterprise Technology companies. We have been early investors in disruptive category leaders like Palantir, Healthline, Babbel and Netli.
We are a global investor active in all the major western venture capital hubs - San Fransisco, Seattle, Los Angeles, Boston, New York, London, Berlin and Tel Aviv. Our largest portfolio cluster is in California.
We typically invest at either Series A or B. However, we are flexible and have invested in late stage companies and have done the occasional seed financing. We typically lead rounds and take board seats. However, where there is a strong syndicate and a smaller opportunity we are happy to participate as followers and board observers. Our investment range is $1m to $10m.
We back talented, ambitious entrepreneurs and management teams who have the drive to disrupt markets and build category leaders.
Our companies share a common drive to disrupt and transform their markets through the application of data, technology and analytics. Our portfolio spans 15 time zones and multiple industry sectors. Each of our companies is part of a large extended family that also includes the entire RELX Group.